BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 10, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Oral belinostat: Completed Phase II enrollment

Topotarget completed enrollment of 88 patients in an open-label, international Phase II trial evaluating carboplatin and paclitaxel with or without belinostat. Patients will receive IV belinostat on days 1-3 and oral...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >